Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment (Q40117235)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment |
scientific article |
Statements
1 reference
Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment (English)
1 reference
David McCormick
Katharina Erb-Zohar
Zhanna D Kobalava
Hans-Peter Stobernack
Holger Zimmermann
Helga Rübsamen-Schaeff
18 July 2017
1 reference
1 reference
1 reference
1 reference
1 reference